6 articles
ASP Isotopes Inc. plans to commence commercial helium production and expand stable isotope facilities, including Silicon-28 and Carbon-14, within six months. Initial shipments from its South African p
ASP Isotopes outlined a plan to commercialize helium, isotopes, and nuclear fuel projects within six months to drive revenue. Key initiatives include silicon-28, carbon-14, and ytterbium-176 productio
ASP Isotopes reported 50% organic revenue growth in PET Labs and near-commercial production of Silicon-28 and Ytterbium-176. The company highlighted helium production plans amid global shortages while
Sensient Technologies reported strong Q2 results with total revenue rising 11.6% to $462.1 million, driven by its Color Group which increased revenue 20.6% to $216.1 million. CEO Paul Manning expresse
ASP Isotopes and ENDRA Life Sciences announced a webinar for Noble Africa, a proposed spin-out aiming to become a Nasdaq-listed helium company. The project leverages Renergen's Virginia Gas Project fo
ASP Isotopes filed an amendment to its 2025 annual report, disclosing CEO Paul Mann's $16.8 million compensation and nearly $400 million market value. The report noted over 125 million common shares o
ChemBrief